Category: Medical
Medtronic recalls disposable diabetes infusion sets over risk of causing hypoglycemia
Medical device manufacturer Medtronic Plc is recalling disposable diabetes infusion sets as a possible defect may trigger excessive doses of insulin to the diabetic user, putting them at risk of hypoglycemia.
The recall reportedly affects insulin infusion sets distributed all over the world.
The device, connected to an insulin pump, features thin plastic tubing with a needle or cannula at the end to carry insulin into the body when needed. However, apparently, “one in every two million” sets may contain a “complication”.
Continue Reading…
NICE calls for U.K. surgery ban on vaginal mesh implants
The infamous mesh implants that’s sewn into vagina walls which has reportedly caused multiple injuries and excruciating pain for many women may now be finally banned for good in the U.K.
Those women who had the ‘minor’ routine surgery to help treat organ prolapses and mild incontinence, but then went on to suffer serious and painful complications has prompted the U.K.’s National Institute for Health and Care Excellence (NICE) to recommend that the implants shouldn’t be used in treatment any more at all, only for research.
This is a change to previous NICE guidelines that were more about taking extreme precautions when using the mesh devices.
Continue Reading…
Hospitals and Doctors warned over using Intercept Pharmaceuticals liver disease drug
Regulators have issued Doctors and Hospitals with a warning over Intercept Pharmaceuticals liver disease drug after 19 people have reportedly died after taking too much of it.
Regulators also noted 11 cases of serious liver injury after taking the drug as well.
The warning prompted the company’s shares to reportedly plummet down by 24.9%, to $73.70. The drop is thought to be the company’s biggest loss since November 2014, Bloomberg reports.
Continue Reading…
Class 4 drug alert for Kyowa Kirin Bleo-Kyowa Powder Solution
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug alert for the Bleo-Kyowa powder over a ‘minor’ defect being reported.
The agency cites glass particles being detected in a batch of the medicine back in April 2017.
Hospitals, pharmacies and other healthcare providers are requested to take caution in using the Bleomycin Sulphate powder that acts as an anticancer chemotherapy medicine.
Continue Reading…
Ceftazidime antibiotic concentration may deteriorate if stored at the wrong temperature
The Medicines and Healthcare Products Regulatory Agency (MHRA) has launched a medical device alert over the test disc for the antibiotic ‘Ceftazidime’, warning that storing the test discs at the wrong temperature can increase the chances of false resistance results.
The antibiotic is used to treat all sorts of bacterial infections including joint infections, sepsis, pneumonia, urinary tract infections and more. In cases where the Ceftazidime test disc was not frozen between the temperatures of +2o and -20o, notably at +8o, the antibiotic’s shelf-life may have been degraded.
Continue Reading…
Thousands of patients sue 3M for allegedly causing infections
Over 4,000 patients reportedly contracted serious infections after using 3M’s warm air blower blanket post-operation that has allegedly deposited infectious bacteria into their incisions.
Most of the patients reportedly underwent joint surgery and used the blanket to keep warm during the procedure. The deep-joint infections have reportedly caused septic arthritis in some cases. The inflammation of a joint through infection can be very painful and cause swelling, requiring treatment with anti-biotics.
Continue Reading…
Rivaroxaban recalled over rogue blister strips of reduced strength tablets
The Medicines and Healthcare Products Regulatory Authority (MHRA) has announced a recall over Xarelto 20mg film-coated tablets made by Strathclyde Pharmaceuticals Ltd. Better known as Rivaroxaban, the tablets are packaged into blister strips with the weight labelled on one side.
A batch is reportedly affected by the recall following reports of rogue blister strips carrying 15mg tablets finding their way into the twin pack 20mg tablets.
The batch number in question is BXHHDR1, due to expire in September 2019. The 28-tablet packets were reportedly first distributed on 18th September 2017.
Continue Reading…
MHRA issues warning for Gentamicin Sulphate Active Pharmaceutical Ingredient over increased levels of histamine
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued an alert over batches of Gentamicin Sulphate Active Pharmaceutical Ingredient (API) for trace contamination of histamine.
The situation is reportedly not serious enough to warrant a recall.
Gentamicin is a bactericidal used an as active ingredient for antibiotics. The MHRA was made aware that testing of the finished products has uncovered higher levels of histamine than expected. The unwanted histamine is thought to be a residual from the manufacturing process, with the potentially affected range between July 2014 and June 2017.
Continue Reading…
Servier to face French Courts over deaths reportedly linked to diet pill
Pharmaceutical drug maker Servier are set to be facing French prosecutors in Court over hundreds of deaths that have reportedly been associated with its weight-loss pill, Mediator.
Once marketed as a diabetes treatment, the drug was widely prescribed as a diet-pill as it apparently helped to suppress appetites. However, it has since been linked to over 500 deaths in France, becoming one of the nation’s worst health scandals.
The U.K. never authorised the drug, but Mediator may have nonetheless found its way across the channel through online markets.
Continue Reading…
Regulatory advice on Kratom drug after 36 deaths
Regulators have issued an advisory warning on 14th November to stop people taking Kratom after 36 deaths have been possibly associated with the drug.
Already banned in several countries, the “pick-me-up” natural drug is created from picked Kratom leaves from jungles all over South East Asia. It was originally used by farm labourers to help them get through working on the fields.
Kratom’s active ingredient is Mitragynine – a chemical that has adverse effects such as nausea; loss of appetite; constipation; dry mouth; trouble sleeping; and brain fatigue. Kratom itself can produce side effects of seizures, itching, increased sensitivity to pain, sweating, liver damage and addiction.
Continue Reading…
Court dismisses Boston Scientific’s appeal over £20 million settlement for pelvic mesh lawsuit
A federal court has dismissed Boston Scientific’s appeal against a £20 million settlement sum awarded to four claimants who sued the company for alleged defective pelvic mesh implants.
The claimants argued that the Pinnacle mesh used to treat pelvic organ prolapse and female stress urinary incontinence was defective and caused significant pain and injuries.
Pain, bleeding and infection are potentially commonplace if the devices fail and the plastic mesh fuses and cuts in to the patient. As they cannot usually remove the mesh from the vaginal walls, the outcome for those whose devices fail can be lifelong and serious.
Continue Reading…
Court orders AbbVie to payout more than £105 million for AndroGel-induced heart attack case
A Court has ordered AbbVie to payout £105 million after they were found to have misrepresented the risks of its testosterone drug known as AndroGel, which lead to one user suffering a heart attack.
A lawyer who helped represent the victim said that the verdict was not just a victory for his client, but served as a warning to companies who put profits above consumer health. He noted that “the large punitive award really reflects that jury’s decision.”
Continue Reading…